<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, Aug. 13, 2018 (HealthDay News) — A $289 million award against Monsanto in a case linking its Roundup week killer to terminal cancer in a former school groundskeeper may lead to similar judgments against the company, according to the man’s lawyers.<\/p>\n
The ruling in favor of Dewayne Johnson, 46, was announced in San Francisco Friday. Roundup contributed to Johnson’s non-Hodgkin lymphoma and Monsanto should have provided a warning label about the potential health risks, the state Superior Court jury said in its decision, the Associated Press<\/i> reported.<\/p>\n
This was the first Roundup-related case filed by a cancer patient against Monsanto, and was expedited because court filings noted that Johnson was dying. The case could set a precedent for many others, according to the AP<\/i>. The company will appeal, said Monsanto spokesman Scott Partridge, who noted that scientific studies and two government agencies have concluded that Roundup does not cause cancer.<\/p>\n
Glyphosate — the active ingredient in Roundup — is safe when used according to label directions, according to the U.S. Environmental Protection Agency. But in 2015, glyphosate was classified as a “probable human carcinogen,” by the International Agency for Research on Cancer, which is part of the World Health Organization, the AP<\/i> reported. Glyphosate is on California’s list of chemicals known to cause cancer.<\/p>\n